Yiquan Li

2 ta ish

Sun Yat-sen University

1. Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer

   Dongbing Ding, Rongpu Liang, Tan Li +12

   Maqola20242 iqtibos

   ABIABI:AkademIndex/2026.other.331972

2. Fibrin gel-based co-delivery of self-adjuvant tumor vaccine and PD-1 blockade for post-surgical gastric cancer immunotherapy

   Jianming Yang, Chi Chen, Dongbing Ding +11

   MaqolaImmunotherapy and Immune ResponsesJournal of Controlled Release20260 iqtibos

   ABIABI:AkademIndex/2026.article.001233